Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELURL PHARMACIE DUFLOS : revenue, balance sheet and financial ratios

SELURL PHARMACIE DUFLOS is a French company founded 5 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BOUGIVAL (78380), this company of category PME shows in 2022 a revenue of 2.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELURL PHARMACIE DUFLOS (SIREN 895201952)
Indicator 2024 2023 2022
Revenue N/C N/C 2 132 840 €
Net income 47 883 € 42 360 € 96 307 €
EBITDA N/C N/C 110 199 €
Net margin N/C N/C 4.5%

Revenue and income statement

In 2024, SELURL PHARMACIE DUFLOS generates positive net income of 48 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 96 k€ -> 48 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

47 883 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 118%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

117.762%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

38.039%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

70.7%

Solvency indicators evolution
SELURL PHARMACIE DUFLOS

Sector positioning

Debt ratio
117.76 2024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average -10 pts over 3 years

In 2024, the debt ratio of SELURL PHARMACIE DUFLOS (117.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
38.04% 2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average +11 pts over 3 years

In 2024, the financial autonomy of SELURL PHARMACIE DUFLOS (38.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
4.03 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of SELURL PHARMACIE DUFLOS (4.03) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 249.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

249.247

Liquidity indicators evolution
SELURL PHARMACIE DUFLOS

Sector positioning

Liquidity ratio
249.25 2024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good +8 pts over 3 years

In 2024, the liquidity ratio of SELURL PHARMACIE DUFLOS (249.25) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
3.52x 2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Good

In 2022, the interest coverage of SELURL PHARMACIE DUFLOS (3.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELURL PHARMACIE DUFLOS

Positioning of SELURL PHARMACIE DUFLOS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELURL PHARMACIE DUFLOS is estimated at 668 482 € (range 465 520€ - 1 000 087€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
465k€ 668k€ 1000k€
668 482 € Range: 465 520€ - 1 000 087€
NAF 5 année 2024

Valuation method used

Net Income Multiple
47 883 € × 14.0x = 668 482 €
Range: 465 520€ - 1 000 087€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELURL PHARMACIE DUFLOS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELURL PHARMACIE DUFLOS

What is the revenue of SELURL PHARMACIE DUFLOS ?

The revenue of SELURL PHARMACIE DUFLOS in 2022 is 2.1 M€.

Is SELURL PHARMACIE DUFLOS profitable?

Yes, SELURL PHARMACIE DUFLOS generated a net profit of 48 k€ in 2024.

Where is the headquarters of SELURL PHARMACIE DUFLOS ?

The headquarters of SELURL PHARMACIE DUFLOS is located in BOUGIVAL (78380), in the department Yvelines.

Where to find the tax return of SELURL PHARMACIE DUFLOS ?

The tax return of SELURL PHARMACIE DUFLOS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELURL PHARMACIE DUFLOS operate?

SELURL PHARMACIE DUFLOS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.